Table 2—

Mean insulin dosages during study

Inhaled insulin
Subcutaneous insulin
Prebreakfast
Prelunch (short-acting)Presupper (short-acting)Bedtime (NPH)Prebreakfast
Prelunch (short-acting)Presupper (short-acting)Bedtime (NPH)
Short-actingNPHShort-actingNPH
Baseline8.3 ± 4.718.1 ± 12.26.6 ± 4.59.5 ± 5.017.1 ± 9.28.6 ± 4.817.2 ± 10.57.1 ± 4.39.7 ± 4.917.3 ± 9.2
Week 63.1 ± 1.7*19.4 ± 12.82.7 ± 1.7*3.8 ± 1.8*17.7 ± 10.28.7 ± 5.117.6 ± 10.96.9 ± 4.910.3 ± 5.219.0 ± 10.0
Week 123.2 ± 1.8*20.4 ± 13.23.0 ± 1.7*4.1 ± 1.9*17.4 ± 10.18.4 ± 5.317.7 ± 11.26.8 ± 5.110.8 ± 5.419.4 ± 10.5
Week 243.3 ± 1.9*21.2 ± 12.83.3 ± 1.8*4.2 ± 1.9*16.9 ± 10.38.9 ± 5.818.0 ± 11.67.0 ± 4.510.9 ± 5.419.8 ± 11.1
  • Data are means ± SD.

  • *

    * mg; all other doses in IU.